Małkiewicz, B.; Gurwin, A.; Karwacki, J.; Nagi, K.; Knecht-Gurwin, K.; Hober, K.; Łyko, M.; Kowalczyk, K.; Krajewski, W.; Kołodziej, A.;
et al. Management of Bladder Cancer Patients with Clinical Evidence of Lymph Node Invasion (cN+). Cancers 2022, 14, 5286.
https://doi.org/10.3390/cancers14215286
AMA Style
Małkiewicz B, Gurwin A, Karwacki J, Nagi K, Knecht-Gurwin K, Hober K, Łyko M, Kowalczyk K, Krajewski W, Kołodziej A,
et al. Management of Bladder Cancer Patients with Clinical Evidence of Lymph Node Invasion (cN+). Cancers. 2022; 14(21):5286.
https://doi.org/10.3390/cancers14215286
Chicago/Turabian Style
Małkiewicz, Bartosz, Adam Gurwin, Jakub Karwacki, Krystian Nagi, Klaudia Knecht-Gurwin, Krzysztof Hober, Magdalena Łyko, Kamil Kowalczyk, Wojciech Krajewski, Anna Kołodziej,
and et al. 2022. "Management of Bladder Cancer Patients with Clinical Evidence of Lymph Node Invasion (cN+)" Cancers 14, no. 21: 5286.
https://doi.org/10.3390/cancers14215286
APA Style
Małkiewicz, B., Gurwin, A., Karwacki, J., Nagi, K., Knecht-Gurwin, K., Hober, K., Łyko, M., Kowalczyk, K., Krajewski, W., Kołodziej, A., & Szydełko, T.
(2022). Management of Bladder Cancer Patients with Clinical Evidence of Lymph Node Invasion (cN+). Cancers, 14(21), 5286.
https://doi.org/10.3390/cancers14215286